focus -WSS

focus

author：comprehensive 2025-10-01 02:14:15 - browse：6166

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

WSS

Even great ERs can’t make up for American health disparities

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

FDA drug safety: Singulair case shows systemic surveillance flaws

Novo Nordisk to expand supply of Wegovy for U.S. patients

Time to name cancers by genetics, not organ of origin, expert says

Vertex non

explore

focus

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Covid misinformation case heads to Supreme Court

Drug repurposing or repositioning? The language matters

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Malaria cases in Florida and Texas: Here’s what you need to know

Quicker fix for pulse oximeters urged during FDA public meeting

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Walensky prepares to leave CDC — and Congress — behind

General Catalyst, Summa Health deal will turn on physician buy

explore

Vertex non

Juul spent big to court Black leaders to promote its e

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Listen: BridgeBio's big week & Lilly's Alzheimer's data

EMA weighs against approval for Mirati's lung cancer drug

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

explore

knowledge

entertainment

hotspot